CollPlant Biotechnologies Ltd (CLGN) reporting calendar
CollPlant Biotechnologies Ltd files periodic reports with the SEC as CLGN on Nasdaq. Atlas tracks 9 filed reports for this issuer, each linked to its original EDGAR accession.
- Latest report
- 20-F
- Period ended
- 31 Dec 2025
- Filed
- 26 Mar 2026
- Reports on record
- 9
Open CLGN market profile
Latest filing on SEC EDGAR ↗
Orthopedic, Prosthetic & Surgical Appliances & Supplies reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 20-F | 31 Dec 2025 | 26 Mar 2026 | 85 days | 0001213900-26-034393 |
| 20-F | 31 Dec 2024 | 26 Mar 2025 | 85 days | 0001013762-25-002502 |
| 20-F | 31 Dec 2023 | 4 Apr 2024 | 95 days | 0001213900-24-030055 |
| 20-F | 31 Dec 2022 | 29 Mar 2023 | 88 days | 0001213900-23-023849 |
| 20-F | 31 Dec 2021 | 24 Mar 2022 | 83 days | 0001213900-22-014666 |
| 20-F | 31 Dec 2020 | 26 Mar 2021 | 85 days | 0001213900-21-017883 |
| 20-F | 31 Dec 2019 | 1 Apr 2020 | 92 days | 0001213900-20-008285 |
| 20-F | 31 Dec 2018 | 1 Apr 2019 | 91 days | 0001213900-19-005360 |
| 20-F | 31 Dec 2017 | 20 Mar 2018 | 79 days | 0001213900-18-003218 |
Source: SEC EDGAR company submissions for CIK 0001631487. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.